Page last updated: 2024-10-17

aminocaproic acid and Deficiency of GP 2b 3a Complex

aminocaproic acid has been researched along with Deficiency of GP 2b 3a Complex in 3 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Binder, A1
Aledort, L1
Cohen, HV1
Wu, P1
Gunaydin, B1
Ozkose, Z1
Pezek, S1

Other Studies

3 other studies available for aminocaproic acid and Deficiency of GP 2b 3a Complex

ArticleYear
Glanzmann's thrombasthenia: meeting the anticoagulation challenge.
    Haemophilia : the official journal of the World Federation of Hemophilia, 2015, Volume: 21, Issue:4

    Topics: Aminocaproic Acid; Aspirin; Clopidogrel; Factor VIIa; Hemorrhage; Humans; Isoantibodies; Male; Middl

2015
Case report: Glanzmann thrombasthenia. Dental patient management for a rare platelet disorder.
    Journal of the New Jersey Dental Association, 2005,Summer, Volume: 76, Issue:3

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Blood Platelets; Humans; Male; Platelet Aggregati

2005
Recombinant activated factor VII and epsilon aminocaproic acid treatment of a patient with Glanzmann's thrombasthenia for nasal polipectomy.
    Journal of anesthesia, 2007, Volume: 21, Issue:1

    Topics: Adult; Aminocaproic Acid; Anesthesia, General; Antifibrinolytic Agents; Blood Loss, Surgical; Drug T

2007